Whitehawk Therapeutics, Inc. Common Stock (WHWK) is a publicly traded Healthcare sector company. As of September 13, 2026, WHWK trades at $4.11 with a market cap of $234.31M and a P/E ratio of -12.46. WHWK moved +1.11% today. Year to date, WHWK is +69.83%; over the trailing twelve months it is +104.48%. Its 52-week range spans $1.39 to $5.50. Analyst consensus is strong buy with an average price target of $8.25. Rallies surfaces WHWK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for WHWK combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $4.11 |
| Market Cap | $234.31M |
| P/E Ratio | -12.46 |
| EPS | $-0.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.50 |
| 52-Week Low | $1.39 |
| Volume | 244.71K |
| Avg Volume | 0 |
| Revenue (TTM) | $7.14M |
| Net Income | $-20.60M |
| Gross Margin | 89.36% |
5 analysts cover WHWK: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.25.